REGENXBIO Inc.
RGNXBiotechnology
$7.20−2.83%As of Oct 30vs prior close
- Market cap
- $475.3M
- P/E (TTM)
- –
- From 52W high
- −54.94%
- EPS (LTM)
- -$3.79
- Revenue (LTM)
- $174.5M
- Net margin
- -112.58%
- Dividend yield
- 0.00%
Nomior Score
24
Distressed LaggardSpeculativeBottom 10% of the scored universe
Growth58
Quality27
Value39
Momentum24
Resilience31
Growth
+49.43%revenue a year over 9 fiscal years
YE16 $4.6MLTM $174.5M
Connections
Revenue to profitQ2 YE26
21% of revenue became net profit, up 353 pts on a year.
Who owns it
2funds